Opioid Policies

collage

Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.

MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.

On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.

MSDC Statement and Testimony on Opioid and Prescription Issues

25th Council information coming soon

 

Big Picture Thinkers Needed for New Public Health Task Force

Oct 11, 2023, 08:47 AM by MSDC staff
The newest MSDC task force will look ahead to help MSDC prepare now for future challenges.

Do you spend your spare minutes concerned about the next set of public health issues? Do you worry DC will not be ready for the next pandemic, epidemic, or ignored health crisis? Do you want to speak with key health leaders and help craft a plan to prepare DC medicine for what's coming next? MSDC has a new opportunity for you.

At its September meeting, the MSDC Board of Directors created a new Public Health Task Force. Over the next nine months, this group will think through and share the major public health issues that will shape society in the coming years.

We are seeking a few physician volunteers who can dedicate about 2-3 hours a month on this important effort. More information is below.

What is the PHTF?
The Public Health Task Force (PHTF) was created by the MSDC Board of Directors to look into the future and identify healthcare trends and issues that the Society can begin to address now. Its work includes:

  • Interviewing key DC health policy leaders and health influentials.
  • Overseeing any public health grants or projects MSDC receives in 2023-2024.
  • Analyzing and recommending action based on what it hears in interactions with officials.

What is the time commitment?
The task force will meet no more than once a month, if that, and its work will conclude by June 2024. The first meeting would be in November or December 2023. Task Force members may also participate in interviews and conversations with stakeholders if their schedule permits. Meetings will be done via Microsoft Teams. Projects and tasks will be monitored using project management software like Asana.

Who is on the task force?
The task force will be composed of 7-10 MSDC voting members, with an emphasis on those in primary care, as well as a representative from the District government and non-MSDC member policy experts. MSDC Treasurer Dr. Tu is the Chair.

How do I learn more or agree to join the task force?
Email Robert Hay at hay@msdc.org. We are aiming to have this task force operational by the MSDC annual meeting on October 27.



Load more comments
avatar
New code

Sample of Legislation MSDC Tracked on Opioid and Prescription Policy

 

Access to Biosimilars Amendment Act (B23-430)

What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.

MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.

Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.

Opioid Labeling Amendment Act (B23-535)

What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.

MSDC position: MSDC supports the legislation.

Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.

Pre-exposure Prophylaxis Insurance Discrimination Amendment Act (B23-36)

What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.

MSDC position: MSDC supports this legislation

Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.